FDA Orphan Exploitation? Are Pharma's Approaches to Orphan Oncology Drug Approvals Fuelling A Push for Reform by the FDA?

May 15, 2018

Educational poster presented at ISPOR 16th Annual International Meeting, Baltimore, May 2018

Educational poster presented at ISPOR 16th Annual International Meeting, Baltimore, May 2018

Previous Article
Is Eunethta Enough? The Remaining Challenges in Navigating the Early European Regulatory and HTA Advice
Is Eunethta Enough? The Remaining Challenges in Navigating the Early European Regulatory and HTA Advice

Next Article
The Future of UK Drug Pricing: The 2014 PPRS - An Interim Review
The Future of UK Drug Pricing: The 2014 PPRS - An Interim Review

Educational poster presented at ISPOR 20th Annual European Congress, November 2017.

×

Register now for full access to all the content

First Name
Last Name
Company Name
Title
Country
Thank you for registering!
Error - something went wrong!